Thomas Wilson Eastling
CIK 1958487 · Chief Financial Officer · last filed 2026-05-06
Thomas Wilson Eastling is a Chief Financial Officer who has filed 5 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing, for GYRE, was dated May 6, 2026. Current disclosed insider exposure totals $99.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$99.6K
1
5
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GYRE | Chief Financial Officer | 15,000 | $6.64 | $99.6K | $0 | 4 | 2026-05-06 |
Recent Filings
5 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-06 | GYRE | Grant (A) | — | $0 | EDGAR |
| 2025-06-06 | GYRE | Grant (A) | — | $0 | EDGAR |
| 2025-04-18 | GYRE | Exer (M) | +15,000 | $104.0K | EDGAR |
| 2024-08-16 | GYRE | Grant (A) | — | $0 | EDGAR |
| 2023-11-01 | — | Grant (A) | — | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.